Prevalence and risk factors for infection with Entamoeba histolytica/dispar/ moshkovskii complex in people living in the slightest and outermost islands of Indonesia.

Entamoeba histolytica (E. histolytica), the causative agent of amoebiasis, is still a global public health problem that cannot be controlled, especially in tropical and subtropical countries. This study was conducted to obtain information about the incidence of Entamoeba histolytica/dispar/ moshkovskii complex infection and the factors that influence it. The prevalence of infection with the Entamoeba histolytica/dispar/moshkovskii complex and the factors that influence it in people living on the smallest and outermost island of Indonesia, Sabang Island, Aceh Province. This study involved 335 respondents aged >= 10 years. Respondents were selected by non-probability sampling technique. Interviews and observations were conducted to identify risk factors. The Entamoeba histolytica/dispar/ moshkovskii complex was identified by direct examination, concentration, and Whitley's trichrome staining techniques. A Chi-Square test was performed to analyze the correlation of risk factors with the incidence of infection. The prevalence of infection with the Entamoeba histolytica/dispar/ moshkovskii complex in the people of Sabang Island was 26.6% (89/335). Source and adequacy of clean water correlated with the incidence of Entamoeba histolytica/dispar/moshkovskii complex infection. Demographic variables are not correlated with the incidence of infection. However, the group of women aged > 61 years, unemployed, unmarried, and earning less than the regional minimum wage tend to be more likely to be found with Entamoeba histolytica/dispar/moshkovskii complex infections. Thus it can be concluded that the prevalence of infection with the Entamoeba histolytica/dispar/moshkovskii complex on Sabang Island is in the high category. The prevalence of E. histolytica as the causative agent of amoebiasis cannot be explained with certainty because the two identical non-pathogenic Entamoeba species cannot be distinguished by microscopic identification. Sources and adequacy of clean water correlate with the incidence of Entamoeba histolytica/dispar/moshkovskii complex infection in the people of Sabang Island.

[1]  E. Sudarnika,et al.  Entamoeba histolytica Neglected Tropical Diseases (NTDs) Agents that Infect Humans and Some Other Mammals: A Review , 2020, E3S Web of Conferences.

[2]  T. Nozaki,et al.  Prevalence and distribution of Entamoeba species in a rural community in northern South Africa , 2020, Food and waterborne parasitology.

[3]  I. Tobbia,et al.  Entamoeba histolytica and amoebic liver abscess in northern Sri Lanka: a public health problem , 2020, Tropical Medicine and Health.

[4]  H. Alborn,et al.  Amoebae , 2019, Ringer.

[5]  M. Teixeira,et al.  A Cross-Sectional Study of Entamoeba histolytica/dispar/moshkovskii Complex in Salvador, Bahia, Brazil , 2019, BioMed research international.

[6]  R. Sarmento-Castro,et al.  Nontravel-related invasive Entamoeba histolytica infection with probable heterosexual transmission , 2019, IDCases.

[7]  A. Haghighi,et al.  Differential detection of Entamoeba histolytica, Entamoeba dispar and Entamoeba moshkovskii in faecal samples using nested multiplex PCR in west of Iran , 2019, Epidemiology and Infection.

[8]  A. Schiller,et al.  Entamoeba Histolytica: Updates in Clinical Manifestation, Pathogenesis, and Vaccine Development , 2018, Canadian journal of gastroenterology & hepatology.

[9]  Juliana de Oliveira Costa,et al.  Prevalence of Entamoeba histolytica and other enteral parasitic diseases in the metropolitan region of Belo Horizonte, Brazil. A cross-sectional study , 2018, Sao Paulo medical journal = Revista paulista de medicina.

[10]  Koji Watanabe,et al.  A Review of the Global Burden, New Diagnostics, and Current Therapeutics for Amebiasis , 2018, Open forum infectious diseases.

[11]  C. Chen,et al.  Primary pulmonary amebic abscess in a patient with pulmonary adenocarcinoma: a case report , 2018, Infectious Diseases of Poverty.

[12]  T. Nozaki,et al.  Genetic diversity of Entamoeba: Novel ribosomal lineages from cockroaches , 2017, PloS one.

[13]  A. Haghighi,et al.  Prevalence of intestinal parasites in referred individuals to the medical centers of Tonekabon city, Mazandaran province , 2016, Gastroenterology and hepatology from bed to bench.

[14]  A. Rizqiani,et al.  Prevalence of intestinal protozoan infections and association with hygiene knowledge among primary schoolchildren in Salahutu and Leihitu districts, Central Maluku regency, Indonesia. , 2016, Tropical biomedicine.

[15]  P. Nowak,et al.  Emergency JJ Stent for Septic Shock under Remifentanil Sedation - An Option when Interventional Radiology is not available , 2015 .

[16]  A. E. Wiria,et al.  Heavy burden of intestinal parasite infections in Kalena Rongo village, a rural area in South West Sumba, eastern part of Indonesia: a cross sectional study , 2015, BMC Public Health.

[17]  T. Žagar,et al.  Drinking Water Quality and the Geospatial Distribution of Notified Gastro-Intestinal Infections , 2015, Zdravstveno varstvo.

[18]  E. Osman,et al.  Prevalence and Risk Factors Associated with Entamoeba histolytica/dispar/moshkovskii Infection among Three Orang Asli Ethnic Groups in Malaysia , 2012, PloS one.

[19]  K. Kain,et al.  A review of amoebic liver abscess for clinicians in a nonendemic setting. , 2012, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[20]  C. Hung,et al.  Entamoeba histolytica infection in men who have sex with men. , 2012, The Lancet. Infectious diseases.

[21]  F. Firoozeh,et al.  Infantile Amoebiasis: A Case Report , 2012, Case reports in infectious diseases.

[22]  F. Sorvillo,et al.  Short report: Amebiasis-related mortality among United States residents, 1990-2007. , 2011, The American journal of tropical medicine and hygiene.

[23]  D. Stark,et al.  Amoebiasis: current status in Australia , 2007 .

[24]  A. L. Leber,et al.  Intestinal amebae. , 1999, Clinics in laboratory medicine.